泽璟制药 (688266)
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 26470.82
- Circulating A-Shares(W): 26470.82
- Earnings Per Share(RMB): -0.3500
- Net Assets Per Share(RMB): 4.3407
- Operating Revenue(W RMB): 59344.01
- Total Profit(W RMB): -9831.96
- **Net Profit Attributable to Parent(W RMB) **: -9341.62
- Net Profit Growth Rate(%): 4.58
- Weighted Return on Equity(%): -7.7800
- Operating Cash Flow Per Share(RMB): -0.0630
- Undistributed Profit Per Share(RMB): -8.3494
- Capital Reserve Per Share(RMB): 11.7468
2. Main Business
The main business covers:
- Innovative drug development and manufacturing in multiple therapeutic areas including oncology, bleeding and blood diseases, and immune-inflammatory diseases
3. Company Basic Information
- Company Name: ZEJI Pharmaceutical
- Listing Date: Unknown
- Industry: Unknown
- Address: Unknown
- Website: Unknown
- Company Profile: Unknown
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| Data not available | - | - | - | - |
5. Concept Sectors
- Concept sectors information not available
Remarks
- Data update date: 2025-09-30
- Data source: Public market information